James Trager, PhD

Dr. James Trager brings over 25 years of technical expertise, strategic execution and development of novel cellular and biologic therapies. He currently serves on the Scientific Advisory Boards of Senti Bio, Cypre Bio, Histone Therapeutics, and Cellazon. Across his career, Dr. Trager managed and integrated the efforts of over 100 scientists, engineers and technicians contributing to the invention and development of multiple cell therapies. PhD: UC Berkeley – Molecular Biology and Biochemistry BA: St. John’s College, Santa Fe New MexicoBA: St. John’s College, Santa Fe New Mexico